How Mounjaro dosing works: the titration schedule and what to expect

What does the Mounjaro dose ladder actually look like?

Tirzepatide (the medicine inside every Mounjaro pen) comes in six UK strengths. Treatment begins at 2.5 mg, then moves to 5 mg, 7.5 mg, 10 mg, 12.5 mg and finally 15 mg if needed and tolerated. You can read about the 5 mg Mounjaro dose in detail if that is where you are in your schedule, but the principles at each rung are the same: spend at least four weeks at a given strength, let your prescriber assess the picture, then decide together whether to go further.

One misconception worth setting aside gently: many people assume they need to reach 15 mg for the medicine to work. That is not how it is designed. The SURMOUNT-1 trial (the pivotal study published in the New England Journal of Medicine) showed meaningful average weight reductions across multiple dose levels, and some people find a mid-range strength suits them well long-term. The goal is the dose that gives you a good clinical response with side effects you can live with.

Each pen contains four weekly doses at the same strength, so one pen covers a full four-week period. If you are curious about how doses translate to volume, there is more detail on the Mounjaro dose in ml page, though in practice most people simply dial the pen and inject, the volume is set for you.

Why does Mounjaro dosing start so low?

The 2.5 mg starting strength is not a therapeutic dose in the weight-loss sense. Its job is adjustment. Mounjaro activates both GIP and GLP-1 receptors, which slows gastric emptying and reduces appetite, effects your digestive system needs a few weeks to get used to. Starting low and titrating slowly is what keeps nausea, vomiting and diarrhoea manageable for most people. The NHS tirzepatide medicines page notes that gastrointestinal side effects are the most common, and they tend to be most noticeable in the first weeks after starting or increasing a dose.

If side effects at a given step are difficult, your prescriber may suggest staying at the current strength for a further four weeks rather than moving up. That is a legitimate clinical choice, not a setback. Rushing the titration tends to make nausea worse without improving results. How you dose Mounjaro over time is a conversation between you and your prescriber, it is not a fixed conveyor belt.

It is also worth knowing that the pen for each strength is a distinct device; you do not adjust a dial between strengths. When your prescriber increases your dose, your next prescription will be for the new strength pen. The Mounjaro four-dose pen page covers how the device works if that is useful.

What is the best dose of Mounjaro for weight loss?

There is no single "best dose" that applies to everyone, and that phrasing, while understandable, is the wrong frame. NICE's appraisal of tirzepatide (TA1026) reflects the trial evidence that higher doses produced greater average weight reductions, but clinical suitability varies. Some people reach their maintenance dose at 10 mg or 12.5 mg and stay there comfortably; others tolerate and benefit from 15 mg. A prescriber weighs your response, your tolerance and your health background.

What the evidence does show clearly is that the full clinical programme reported average body-weight reductions of around 20–21% at 15 mg over 72 weeks in people without type 2 diabetes, figures that place tirzepatide among the most effective weight-management medicines currently licensed in the UK. Whether a given dose gets you to a meaningful outcome is something a prescriber tracks across repeat reviews, not something set on day one.

For context on what long-term dosing might look like once you have reached your maintenance level, the Mounjaro maintenance dose page goes into that question specifically. Cost is a practical part of these decisions too, and the Mounjaro prices page covers what different dose levels typically cost privately in the UK.

Who decides when to change my Mounjaro dose?

Your prescriber. Always. No reputable clinic or pharmacy will let you self-titrate based on what you have read online. At nume (actually at nume) every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is approved; a real clinician reads your update, not a queue for automated software. That review looks at how you have been getting on, whether evidence of your current weight is available, and whether a dose increase is clinically appropriate at this point.

The same principle applies to transfers from another provider: if you arrive at a higher dose, your prescriber will want to see evidence that you have worked through the earlier strengths safely. This is standard practice, not red tape. The Mounjaro overview page covers the broader picture of how the medicine works and what the full treatment journey involves. If you have questions that fall outside what a content page can answer, the FAQs may help, or you can reach the team directly via contact.

When you are ready to speak to a prescriber about your dose, or to start treatment for the first time, the right first step is a clinical consultation. Speak to our prescribers through our free consultation, same-day clinical review, no waiting list.